Concepedia

Steffen Sandman

SS

1

Publications

51

Citations

1

H-Index

2019

Active since

Affiliations

Bayer (Germany)(Current)

Steffen Sandman is an author at Bayer (Germany) specializing in molecular pharmacology, nuclear medicine, and pre-clinical pharmacology.

Top concepts

HealthMedicineNeurologyBrain InjuryNeurosciencePharmacologyEndocrinologyNeuroprotectionPharmacotherapyNuclear Medicine

Publications per year

2019–2019

1

Publications

1

Higher blood–brain barrier penetration of [<sup>14</sup>C]apalutamide and [<sup>14</sup>C]enzalutamide compared to [<sup>14</sup>C]darolutamide in rats using whole-body autoradiography.

Christian Zurth, Steffen Sandman, Dagmar Trummel et al. · Journal of Clinical Oncology · 2019 · 51 citations

Moderate Bbb Penetration, Pharmacotherapy, Experimental Pharmacology +22

Rows per page

1–1 of 1